Need a specific person's email?
Browse Bellerophon Therapeutics's employee directory (about 7 employees) and reveal verified emails free.
Bellerophon Therapeutics's most common email format is First.Last@bellerophon.com (ex. John.Doe@bellerophon.com), used for 98% of bellerophon.com addresses. Bellerophon Therapeutics uses 2 email patterns.
| Format | Example | Share of bellerophon.com |
|---|---|---|
| First.Last@bellerophon.comMost common | John.Doe@bellerophon.com | |
| FiLast@bellerophon.com | JoDoe@bellerophon.com |
Browse Bellerophon Therapeutics's employee directory (about 7 employees) and reveal verified emails free.
Biotechnology ResearchNew Jersey, United States2-10 Employees
Bellerophon Therapeutics is a clinical-stage biotechnology company focused on developing therapies for cardiopulmonary and cardiac diseases by combining novel drugs with delivery devices. Its aim is to advance well-studied molecules through innovative delivery systems to treat diseases with significant unmet clinical need. Based in Warren, New Jersey, the company is a small organization concentrating on discovery and development in the cardiopulmonary space. It has pursued inhaled nitric oxide therapies delivered via a portable device for pulmonary arterial hypertension and other forms of pulmonary hypertension, reflecting an emphasis on new delivery approaches for respiratory and heart conditions. In 2020, the company announced the appointment of a Chief Medical Officer as part of its clinical development efforts.
Most common format
First.Last@bellerophon.com
Example: John.Doe@bellerophon.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.